Generic Drug Pricing Fairness Act
Latest action · Apr 11, 2014 Referred to the Subcommittee on Health.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedApr 9, 2014
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Generic Drug Pricing Fairness Act - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act to require each contract entered into with a prescription drug plan (PDP) sponsor with respect to a PDP the sponsor offers to prohibit the PDP from entering into a contract with any pharmacy benefits manager (PBM) to manage the prescription drug coverage provided under such plan, or to control the costs of the prescription drug coverage under it, unless the PBM adheres to specified criteria when handling personally identifiable utilization and claims data or other sensitive patient data.
Revises requirements for contracts with PDP sponsors to require that the PDP sponsor disclose to applicable pharmacies the sources used for making any update of the prescription drug pricing standard, and if the source for such a standard is not publicly available, disclose to such pharmacies all individual drug prices to be so updated in advance of their use for the reimbursement of claims.
Requires the PDP sponsor, as well, to establish a process to appeal, investigate, and resolve disputes regarding individual drug prices that are less than the pharmacy acquisition price for a drug.
Cosponsors 14
Members who signed on, in the order they did. Signatures ran from Apr 9, 2014 to Nov 12, 2014; 1 is an original cosponsor, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| D-IA | David Loebsack | Original | Apr 9, 2014 |
| R-GA | Austin Scott | May 7, 2014 | |
| R-TX | Joe Barton | May 9, 2014 | |
| D-GA | Sanford D. Bishop, Jr. | May 19, 2014 | |
| R-CO | Mike Coffman | May 22, 2014 | |
| R-AK | Don Young | May 28, 2014 | |
| R-TN | John J. Duncan, Jr. | Jun 17, 2014 | |
| R-FL | Steve Southerland II | Jun 17, 2014 | |
| R-NE | Jeff Fortenberry | Jun 18, 2014 | |
| R-TX | Roger Williams | Jun 18, 2014 | |
| R-AR | Eric A. "Rick" Crawford | Jul 17, 2014 | |
| D-PA | Chaka Fattah | Jul 29, 2014 | |
| R-PA | Lou Barletta | Sep 9, 2014 | |
| R-NY | Richard L. Hanna | Nov 12, 2014 |
Committees 2
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Energy and Commerce Committee | Referred Apr 9, 2014 |
| Health Subcommittee | Referred Apr 11, 2014 | |
| House | Ways and Means Committee | Referred Apr 9, 2014 |
Actions 3
Everything that happened, newest first.
- Apr 11, 2014Referred to the Subcommittee on Health.
- Apr 9, 2014Introduced in House
- Apr 9, 2014Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
In the Congressional Record 1
Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.
| Where | In the Record | Members | Date |
|---|---|---|---|
| House | Debate and remarks H3138–H3141 | Austin Scott R-GA, Doug Collins R-GA | Apr 9, 2014 |
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Constitutional authority
The sponsor’s statement, as printed in the page H3143.
Printed hearings 2
Hearings whose printed record names this bill, newest first: hearings on it, and wider hearings where it came up.
| Number | Hearing | Committee | Held |
|---|---|---|---|
| S. Hrg. 113-859 | WHY ARE SOME GENERIC DRUGS SKYROCKETING IN PRICE?69 pages | Health, Education, Labor, and Pensions Committee | Nov 20, 2014 |
| Serial No. 113-36 | STRENGTHEN AND FORTIFY ENFORCEMENT (SAFE) ACT213 pages | Judiciary Committee | Jun 13, 2013 |
Related bills 2
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| S 867 | Medicare Prescription Drug Program Integrity and Transparency Act of 2013 | Related bill | May 6, 2013 |
| HR 5815 | Generic Drug Pricing Fairness Act | Related bill | Dec 12, 2014 |
Titles 2
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To amend title XVIII of the Social Security Act to provide for pharmacy benefits manager standards under the Medicare prescription drug program to further transparency of payment methodologies to pharmacies, and for other purposes.
- Short Titles as Introduced
- Generic Drug Pricing Fairness Act
Subjects
Assigned by the Library of Congress. Policy area: Health.
Text 1
Each version as it was printed, newest first.
- Apr 9, 2014Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.
